Targeting Radiation-Induced Glioma-Initiating Cells in Patient-Derived Glioblastoma
Anjelica M. Cardenas, Sabrina Sutlief, Frank Pajonk
This study identifies selumetinib as a compound that prevents radiation-induced conversion of non-tumor-initiating cells to glioma-initiating cells in glioblastoma.
bioRxiv · Oct 8, 2025 · PreprintCancer Biology